integrated metrology community.
News
MetroMRT contributes to clinical trial of cancer treatment
The chemical structure of selumetinib
Results of EMRP project MetroMRT (HLT11) implemented in first clinical trial with image-based dosimetry
One of the calibration protocols developed with funding from EMRP project 'Metrology for molecular radiotherapy' MetroMRT and the UK National Measurement and Regulation Office (NMRO) is being used for implementation of dosimetry in a new clinical trial - the first to use image-based dosimetry.
The Cancer Research UK funded clinical trial, SEL-I-METRY, is investigating the potential use of the drug selumetinib to resensitise thyroid cancers which have stopped responding to radioiodine therapy. Patients are expected to be recruited in January 2016.
Molecular radiotherapy (MRT) has the potential to become a valuable tool in the treatment of cancer. However, widespread MRT use is being hampered by a reluctance to adopt individual patient-tailored dosimetry, which is perceived to be difficult and resource intensive.
The MetroMRT project 'Metrology for molecular radiotherapy' developed the metrology needed to support routine use of individual MRT patient dosimetry, and working with the MRT community to develop standard procedures incorporating both calibration and verification.
Information
- HLT11 project page
- EMRP,
- Health,
Developing a metrologically-based field assessment of glare and obtrusive light more
Standardising industrial procedures for the magnetic properties of devices leading to the improved quality of a wide variety of products more
Implementing quantum-based pressure measurement techniques in European industries more
Developing reference materials for mass spectroscopy to monitor radioactive and stable isotope pollution in the environment more
Development of the metrological network needed to realise and implement 6G technology more